Can We Ensure the Safe Use of Known Human Teratogens? Margaret A. HoneinCynthia A. MooreJ. David Erickson Current Opinion 19 October 2012 Pages: 1069 - 1080
Overview of the Tolerability of Gefitinib (IRESSAâ„¢) Monotherapy Beverley ForsytheKaren Faulkner Review Article 19 October 2012 Pages: 1081 - 1092
Benefit-Risk Assessment of Ropivacaine in the Management of Postoperative Pain Wolfgang ZinkBernhard M. Graf Review Article 19 October 2012 Pages: 1093 - 1114
Fab Antibody Fragments Robert J. FlanaganAlison L. Jones Review Article 19 October 2012 Pages: 1115 - 1133
Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents Paz TorenSharon RatnerAbraham Weizman Review Article 19 October 2012 Pages: 1135 - 1156
Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction Raymond G. SchliengerLorenz M. FischerChristoph R. Meier Original Research Article 19 October 2012 Pages: 1157 - 1165